These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8950954

  • 1. [PAF receptor antagonist in asthma therapy].
    Sagara H, Makino S, Fukuda T.
    Nihon Rinsho; 1996 Nov; 54(11):3056-61. PubMed ID: 8950954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PAF antagonism as an approach to the treatment of airway hyperreactivity.
    Meade CJ, Heuer H.
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV, Eberhart SW, Robinson NE, Rice R, Gray PR.
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO.
    Agents Actions Suppl; 1991 Feb; 34():229-45. PubMed ID: 1793067
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM, Stewart AG, Goulter CM, Morgan TO, Harris PJ.
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [Abstract] [Full Text] [Related]

  • 13. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
    Saumweber DM, Bergmann R, Gokel M, Brecht HM, Hammer C.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):576-8. PubMed ID: 1990613
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K.
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The interaction between PAF, platelets and eosinophils in bronchial asthma.
    Page CP, Coyle AJ.
    Eur Respir J Suppl; 1989 Jun; 6():483s-487s. PubMed ID: 2679601
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M, Nishioka E, Kanoh R, Tachibana M, Fukuishi N.
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.